The largest database of trusted experimental protocols

Accuscript rt

Manufactured by Agilent Technologies

The Accuscript RT is a real-time reverse transcription system designed for accurate and reliable RNA analysis. It provides a streamlined workflow for the conversion of RNA to cDNA, enabling efficient downstream gene expression studies.

Automatically generated - may contain errors

4 protocols using accuscript rt

1

RT-qPCR and RT-PCR Amplification of Long RNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Accuscript RT (Agilent Technologies) was used to convert and amplify long RNAs to cDNAs with 500 ng of RNA used per RT reaction. Random hexamer RT primers were used to amplify cDNA for RT-qPCR while oligo-dT primers were used for RT-PCR assays. 1 μL cDNA product was used to amplify full length RNAs using a 25 μL Phusion DNA polymerase reactions. Taqman RNA assays (Life Technologies) were performed as indicated. Briefly, 10 ng of total RNA was used per individual RT reaction; 0.67 mL of the resultant cDNA was used in 10 μL qPCR reactions. 1 μL of the resultant cDNA was used in a 10 μL qPCR reaction. qRT-PCR reactions were conducted in 384-well plates using the Biorad CFX384 Real-Time System. All C(t) values were ≤ 40. Triplicate C(t) values were averaged and normalized against b-actin. Fold-changes were calculated using the ΔΔC(t) method, where Δ = C(t)RNA – C(t)U6 snRNA/B-Actin, and ΔΔC(t) = ΔC(t)tumor – ΔC(t)control, and FC = 2−ΔΔC(t). In some cases, RT-PCR bands were electrophoresed and band intensity measured using AlphaView.
+ Open protocol
+ Expand
2

Rab13 cDNA Synthesis and Plasmid Construction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Rab13 cDNA was synthesized using Accuscript RT (Agilent Technologies). Rab13HA cDNA was inserted into the CMVMIR plasmid using BamHI and EcoRV (New England Biolabs). CRISPR-Display plasmids were a gracious gift from David Shechner of the Rinn Laboratory at Harvard University. All plasmids were confirmed by sequencing (Genewiz).
+ Open protocol
+ Expand
3

Sensitive HIV-1 vRNA Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viral RNA was isolated from plasma samples obtained after initial maximal VL suppression was achieved (<50 vRNA copies/mL), according to the previously described ultracentrifugation based vRNA extraction procedure (See above). Viral RNA was converted to cDNA using AccuScript RT (Agilent, Santa Clara CA) in a gene-specific primed cDNA synthesis reaction. The previously described reaction conditions were modified to use 21.4 µL of vRNA template, 2 µM of the gene-specific primer RT-SGA-GSP (Table S1), and omitted the initial 25°C elongation step. After cDNA synthesis, 10 U of RNAse H (NEB) and 4.4 µL 10X RNaseH buffer was added to the reaction mixture which was then incubated at 37°C for 20 min. The first round of PCR (Table S2; SGA-RT-Round 1) was performed by preparing 16, 25 µL reactions containing 2.5 µL of cDNA per reaction. A nested PCR amplification step (Table S2; SGA-RT-Round 2) was performed in a 20 µL reaction volume containing 0.5 µL of 1st round PCR product. PCR reactions were screened by agarose gel electrophoresis. Positive amplification products were reamplified in a 50 µL reaction volume, purified, and bi-directionally sequenced using primers RT-SGASeqF and RT-SGASeqR (Table S1) by the University of Michigan's DNA sequencing core according to protocols for Applied Biosystems DNA Sequencers (Model 3730 XL).
+ Open protocol
+ Expand
4

Cloning and Silencing of Rab13 in CRC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Rab13 cDNA was synthesized using Accuscript RT (Agilent Technologies) from RNA purified from DKO-1 CRC cells. Rab13HA cDNAs were inserted into the pcDNA3.1 + (Zeocin) plasmid using BamHI and NotI (New England Biolabs). shRNA plasmids were a gift from the Vanderbilt shRNA Core (Vanderbilt University). Rab13 shRNA #1 targeted the 3′UTR while shRNA #2 targeted the 3′ end of the Rab13 ORF. All plasmids were confirmed by sequencing (Genewiz, South Plainfield, NJ, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!